BattellePharma Announces Additional Compound in Development for GlaxoSmithKline; Second Compound Also Utilizes BattellePharma's Mystic Inhalation Technology.Business Editors & Health/Medical Writers BIOWIRE2K BattellePharma, Inc., today announced it began work on a second new chemical entity with GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ) for treating asthma that will utilize BattellePharma's proprietary inhalation technology. The terms of the second agreement were not disclosed. BattellePharma's proprietary Mystic(TM) electrohydrodynamic technology delivers a soft cloud of uniformly sized particles directly to the lungs with a significant improvement in efficiency without the need for liquid propellants Any liquid combustible fed to the combustion chamber of a rocket engine. or other pressurized pres·sur·ize tr.v. pres·sur·ized, pres·sur·iz·ing, pres·sur·iz·es 1. To maintain normal air pressure in (an enclosure, as an aircraft or submarine). 2. systems used in competitive inhalers. The aerosol mist is delivered using the patient's own breath so the patient can easily control the drug delivery. The delivery mechanism is especially suited for use with infants, young children, seniors, and patients with impaired respiratory function. Mystic devices can be adapted to deliver a wide range of medications. "More and more pharmaceutical companies are recognizing pulmonary drug delivery can provide safer, better results than injections or oral dosage forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. for many conditions," said Dennis Cearlock, Ph.D., CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BattellePharma. "GlaxoSmithKline is the world's leading respiratory company and we're pleased our initial studies have encouraged them to pursue development of a second compound utilizing our Mystic delivery technology. Our partnership with GSK will enable us to accelerate the development of our drug delivery platforms -- the Mystic inhalation and novel formulations technologies." About BattellePharma BattellePharma is a pre-public specialty pharmaceutical company leveraging science and technology to design more effective medicines. The company has a growing portfolio of nine products in development, with several in early clinical trials. BattellePharma has partnerships with numerous pharmaceutical corporations, including Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. , Corus Pharma, GlaxoSmithKline, Pfizer Inc., Viasys Healthcare, and ViroPharma, Inc. and is a subsidiary of Battelle Memorial Institute The Battelle Memorial Institute is a private not-for-profit applied science and technology development company headquartered in Columbus, Ohio. The institute opened in 1929 but traces its origins to the 1923 will of Ohio industrialist Gordon Battelle which provided for its , the world's largest independent and private research and development organization. For more information on BattellePharma, reference the company's website at www.battellepharma.com. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion